Pantoprazol Sun (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Sun, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Sun is a proton pump inhibitor that acts on the acid‑secretion pathway of the stomach. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates healing of erosive lesions. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.

Pantoprazol Sun may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild, intermittent pain. - Diarrhoea: loose, watery stools. - Nausea: feeling of queasiness. - Abdominal pain: mild cramping. - Flatulence: excess intestinal gas. - Constipation: infrequent, hard stools.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, dizziness or trouble breathing. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fracture risk: especially with long‑term use. - Liver enzyme elevation: abnormal blood test results.

When prescribing Pantoprazol Sun, clinicians should consider several safety aspects. - Renal impairment: dose adjustment may be required. - Hepatic impairment: monitor liver function tests. - Elderly patients: assess fall risk due to potential electrolyte changes. - Concomitant use with NSAIDs: increased ulcer risk. - Long‑term therapy: evaluate need for periodic reassessment. - Store below 25°C: keep in the original packaging, protect from moisture and light.

Pantoprazol Sun can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole oral suspension: reduced absorption due to higher gastric pH. - Atazanavir: markedly decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR values. - Methotrexate: reduced renal clearance may raise serum levels. - Digoxin: slight increase in serum concentration.